Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)

Verhoeff, Sr; Es, S; Boon, E; van Helden, E; Angus, L; Elias, S; Oosting, S; Aarntzen, E; Brouwers, A; Heskamp, S; Hoekstra, Os; Verheul, Hm; Van der Veldt AAM,; de Vries EGE,; Boerman, O; van der Graaf WTA,; Oyen, W; van Herpen CML,

Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) / Verhoeff, Sr; Es, S; Boon, E; van Helden, E; Angus, L; Elias, S; Oosting, S; Aarntzen, E; Brouwers, A; Heskamp, S; Hoekstra, Os; Verheul, Hm; Van der Veldt, Aam; de Vries, Ege; Boerman, O; van der Graaf, Wta; Oyen, W; van Herpen, Cml. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 29:8(2018).

Titolo:	Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)
Autori:	Verhoeff SR Es S Boon E van Helden E Angus L Elias S Oosting S Aarntzen E Brouwers A Heskamp S Hoekstra OS Verheul HM Van der Veldt AAM de Vries EGE Boerman O van der Graaf WTA OYEN, Willem Jozef Gerard van Herpen CML mostra contributor esterni nascondi contributor esterni
Data di pubblicazione:	2018
Rivista:	ANNALS OF ONCOLOGY
Handle:	http://hdl.handle.net/11699/3573
Appare nelle tipologie:	1.5 Abstract in rivista

File in questo prodotto:

Non ci sono file associati a questo prodotto.

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11699/3573

Citazioni

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

CINECA IRIS Institutional Research Information System

File in questo prodotto: